Cidara Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Cidara Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cidara Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cidara Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $45M | 474k | 95.76 |
| 2025-06-30 | $8.7M | 178k | 48.71 |
| 2025-03-31 | $1.4M | 67k | 21.54 |
| 2024-12-31 | $1.3M | 47k | 26.88 |
| 2024-09-30 | $63k | 5.9k | 10.75 |
| 2024-06-30 | $18k | 1.5k | 11.94 |